Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Fenretinide MeSH Descriptor Data 2025


MeSH Heading
Fenretinide
Tree Number(s)
D02.455.326.271.665.202.495.270
D02.455.426.392.368.367.379.249.700.270
D02.455.849.131.495.270
D23.767.261.700.270
Unique ID
D017313
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D017313
Scope Note
A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.
Entry Term(s)
4-HPR
4-Hydroxyphenylretinamide
Fenretinide, 13-cis-Isomer
Fenretinimide
MCN-R-1967
N-(4-Hydroxyphenyl)-trans-Retinamide
N-(4-Hydroxyphenyl)retinamide
Pharm Action
Antineoplastic Agents
Anticarcinogenic Agents
Registry Numbers
187EJ7QEXL
75686-07-6
0
Related Numbers
65646-68-6
75686-07-6
CAS Type 1 Name
Retinamide, N-(4-hydroxyphenyl)-
Previous Indexing
Tretinoin/analogs & derivatives (1979-1992)
Public MeSH Note
93; FENRETINIDE was indexed under TRETINOIN/analogs & derivatives 1979-92
Online Note
use FENRETINIDE (NM) to search FENRETINIDE 1979-92
History Note
93; was FENRETINIDE (NM) 1979-92
Date Established
1993/01/01
Date of Entry
1992/05/19
Revision Date
2013/07/08
Fenretinide Preferred
Fenretinide, 13-cis-Isomer Related
MCN-R-1967 Narrower
page delivered in 0.145s